FDA Panel Recommends Novavax COVID Vaccine Despite Heart Inflammation Concerns
The two-dose Novavax COVID-19 vaccine on Tuesday came one step closer to obtaining Emergency Use Authorization after advisors to the U.S. Food and Drug Administration recommended its use in the U.S.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed